Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Relamorelin

Product Specifications

UNSPSC Description

Relamorelin (RM-131), a pentapeptide ghrelin analog, is a selective ghrelin/growth hormone secretagogue receptor (GHSR) agonist with a Ki of 0.42 nM for GHS-1a receptor. Relamorelin is centrally penetrant. Relamorelin increases growth hormone levels and accelerates gastric emptying. Relamorelin has the potential for cachexia, gastroparesis, and gastric/intestinal dysmobility disorders research[1][2][3][4].

Target Antigen

GHSR

Type

Peptides

Related Pathways

GPCR/G Protein

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/relamorelin.html

Solubility

10 mM in DMSO

Smiles

O=C(C1CCNCC1)N[C@H](CC2=CSC3=CC=CC=C23)C(N[C@@H](C(N[C@@H](CC4=CC=CC=C4)C(NC5(CCNCC5)C(N)=O)=O)=O)CC6=CNC7=CC=CC=C67)=O

Molecular Weight

790.97

References & Citations

[1]DeBoer MD, et, al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology. 2007 Jun;148(6):3004-12.|[2]Fischer K, et, al. The Pentapeptide RM-131 Promotes Food Intake and Adiposity in Wildtype Mice but Not in Mice Lacking the Ghrelin Receptor. Front Nutr. 2015 Jan 12;1:31.|[3]Zatorski H, et, al. Relamorelin and other ghrelin receptor agonists - future options for gastroparesis, functional dyspepsia and proton pump inhibitors-resistant non-erosive reflux disease. J Physiol Pharmacol. 2017 Dec;68(6):797-805.|[4]Matthew Heckroth, et al. Nausea and Vomiting in 2021: A Comprehensive Update. J Clin Gastroenterol. 2021 Apr 1;55(4):279-299.|[5]Victor Chedid, et al. Relamorelin for the treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs. 2017 Oct;26(10):1189-1197.

Shipping Conditions

Room temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-19884/Relamorelin-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-19884/

Clinical Information

Phase 3

CAS Number

661472-41-9

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Endothelial Cell Specific Molecule 1 (ESM1) Polyclonal Antibody
CAU24252-01 100 µL

Endothelial Cell Specific Molecule 1 (ESM1) Polyclonal Antibody

Ask
View Details
Endothelial Cell Specific Molecule 1 (ESM1) Polyclonal Antibody
CAU24252-02 200 µL

Endothelial Cell Specific Molecule 1 (ESM1) Polyclonal Antibody

Ask
View Details
Nsun2 (NM_145354) Mouse Untagged Clone
MC221376 10 µg

Nsun2 (NM_145354) Mouse Untagged Clone

Ask
View Details
Oct-2 (H-3)
sc-377476 200 µg/mL

Oct-2 (H-3)

Ask
View Details
(R) -3-Amino-3- (Thiophen-2-Yl) Propanoic Acid
OR1028491-01 100 mg

(R) -3-Amino-3- (Thiophen-2-Yl) Propanoic Acid

Ask
View Details
(R) -3-Amino-3- (Thiophen-2-Yl) Propanoic Acid
OR1028491-02 250 mg

(R) -3-Amino-3- (Thiophen-2-Yl) Propanoic Acid

Ask
View Details